413 related articles for article (PubMed ID: 21385661)
1. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel tetrahydronaphthyl azoles and related cyclohexyl azoles as antileishmanial agents.
Marrapu VK; Srinivas N; Mittal M; Shakya N; Gupta S; Bhandari K
Bioorg Med Chem Lett; 2011 Mar; 21(5):1407-10. PubMed ID: 21295472
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities.
Bazin MA; Loiseau PM; Bories C; Letourneux Y; Rault S; El Kihel L
Eur J Med Chem; 2006 Oct; 41(10):1109-16. PubMed ID: 16949702
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
Peyron C; Benhida R; Bories C; Loiseau PM
Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
[TBL] [Abstract][Full Text] [Related]
7. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of chromenochalcones and evaluation of their in vitro antileishmanial activity.
Narender T; Khaliq T; Shweta ; Nishi ; Goyal N; Gupta S
Bioorg Med Chem; 2005 Dec; 13(23):6543-50. PubMed ID: 16185885
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of new difluoromethyl azoles as antileishmanial agents.
Ferreira SB; Costa MS; Boechat N; Bezerra RJ; Genestra MS; Canto-Cavalheiro MM; Kover WB; Ferreira VF
Eur J Med Chem; 2007; 42(11-12):1388-95. PubMed ID: 17445951
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
[TBL] [Abstract][Full Text] [Related]
11. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
Kumar A; Katiyar SB; Gupta S; Chauhan PM
Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
[TBL] [Abstract][Full Text] [Related]
12. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents.
Singh FV; Vatsyayan R; Roy U; Goel A
Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani.
Gupta L; Sunduru N; Verma A; Srivastava S; Gupta S; Goyal N; Chauhan PM
Eur J Med Chem; 2010 Jun; 45(6):2359-65. PubMed ID: 20371140
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agents.
Kumar S; Tiwari A; Suryawanshi SN; Mittal M; Vishwakarma P; Gupta S
Bioorg Med Chem Lett; 2012 Nov; 22(21):6728-30. PubMed ID: 23031588
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB
Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of indolyl glyoxylamides as a new class of antileishmanial agents.
Chauhan SS; Gupta L; Mittal M; Vishwakarma P; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2010 Nov; 20(21):6191-4. PubMed ID: 20850302
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
Agarwal KC; Sharma V; Shakya N; Gupta S
Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
